174 related articles for article (PubMed ID: 28806076)
1. Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A
Xia L; Burger WAC; van Veldhoven JPD; Kuiper BJ; van Duijl TT; Lenselink EB; Paasman E; Heitman LH; IJzerman AP
J Med Chem; 2017 Sep; 60(17):7555-7568. PubMed ID: 28806076
[TBL] [Abstract][Full Text] [Related]
2. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
3. Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.
Priego EM; Pérez-Pérez MJ; von Frijtag Drabbe Kuenzel JK; de Vries H; Ijzerman AP; Camarasa MJ; Martín-Santamaría S
ChemMedChem; 2008 Jan; 3(1):111-9. PubMed ID: 18000937
[TBL] [Abstract][Full Text] [Related]
4. A binding kinetics study of human adenosine A
Xia L; Kyrizaki A; Tosh DK; van Duijl TT; Roorda JC; Jacobson KA; IJzerman AP; Heitman LH
Biochem Pharmacol; 2018 Jul; 153():248-259. PubMed ID: 29305857
[TBL] [Abstract][Full Text] [Related]
5. Effect of Nitrogen Atom Substitution in A
Azuaje J; Jespers W; Yaziji V; Mallo A; Majellaro M; Caamaño O; Loza MI; Cadavid MI; Brea J; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
J Med Chem; 2017 Sep; 60(17):7502-7511. PubMed ID: 28792759
[TBL] [Abstract][Full Text] [Related]
6. Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A
Yang X; van Veldhoven JPD; Offringa J; Kuiper BJ; Lenselink EB; Heitman LH; van der Es D; IJzerman AP
J Med Chem; 2019 Apr; 62(7):3539-3552. PubMed ID: 30869893
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
[TBL] [Abstract][Full Text] [Related]
8. New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Merighi S; Varani K; Borea PA
J Med Chem; 2005 Jul; 48(14):4697-701. PubMed ID: 16000006
[TBL] [Abstract][Full Text] [Related]
9. Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonists.
Azuaje J; Carbajales C; González-Gómez M; Coelho A; Caamaño O; Gutiérrez-de-Terán H; Sotelo E
Future Med Chem; 2015; 7(11):1373-80. PubMed ID: 26230877
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: potent and selective adenosine A3 receptor antagonists.
Banda V; Chandrasekaran B; Köse M; Vielmuth C; Müller CE; Chavva K; Gautham SK; Pillalamarri S; Mylavaram R; Akkinepally R; Pamulaparthy S; Banda N
Arch Pharm (Weinheim); 2013 Oct; 346(10):699-707. PubMed ID: 23996524
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of novel adenosine A
Barkan K; Lagarias P; Stampelou M; Stamatis D; Hoare S; Safitri D; Klotz KN; Vrontaki E; Kolocouris A; Ladds G
Sci Rep; 2020 Nov; 10(1):20781. PubMed ID: 33247159
[TBL] [Abstract][Full Text] [Related]
12. Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.
Ranganathan A; Stoddart LA; Hill SJ; Carlsson J
J Med Chem; 2015 Dec; 58(24):9578-90. PubMed ID: 26592528
[TBL] [Abstract][Full Text] [Related]
13. Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists.
Xia L; de Vries H; Lenselink EB; Louvel J; Waring MJ; Cheng L; Pahlén S; Petersson MJ; Schell P; Olsson RI; Heitman LH; Sheppard RJ; IJzerman AP
J Med Chem; 2017 Dec; 60(23):9545-9564. PubMed ID: 29111736
[TBL] [Abstract][Full Text] [Related]
14. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation.
Varano F; Catarzi D; Squarcialupi L; Betti M; Vincenzi F; Ravani A; Varani K; Dal Ben D; Thomas A; Volpini R; Colotta V
Eur J Med Chem; 2015; 96():105-21. PubMed ID: 25874336
[TBL] [Abstract][Full Text] [Related]
15. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S
J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825
[TBL] [Abstract][Full Text] [Related]
16. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
17. Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A
Lee Y; Hou X; Lee JH; Nayak A; Alexander V; Sharma PK; Chang H; Phan K; Gao ZG; Jacobson KA; Choi S; Jeong LS
J Med Chem; 2021 Sep; 64(17):12525-12536. PubMed ID: 34435786
[TBL] [Abstract][Full Text] [Related]
18. The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.
Poli D; Catarzi D; Colotta V; Varano F; Filacchioni G; Daniele S; Trincavelli L; Martini C; Paoletta S; Moro S
J Med Chem; 2011 Apr; 54(7):2102-13. PubMed ID: 21401121
[TBL] [Abstract][Full Text] [Related]
19. Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.
Tosh DK; Paoletta S; Chen Z; Moss SM; Gao ZG; Salvemini D; Jacobson KA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3302-6. PubMed ID: 24969016
[TBL] [Abstract][Full Text] [Related]
20. Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.
Squarcialupi L; Catarzi D; Varano F; Betti M; Falsini M; Vincenzi F; Ravani A; Ciancetta A; Varani K; Moro S; Colotta V
Eur J Med Chem; 2016 Jan; 108():117-133. PubMed ID: 26638043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
